• Study on the Safety and Effects of BAY 2599023 (Peboctocogene Camaparvovec) for Adults with Severe Hemophilia A

    Not recruiting

    2 1 1
    Investigated Drugs:
    Bulgaria France Germany The Netherlands

  • Study on Holmium-166 TARE and Maintenance Therapy with Capecitabine, Bevacizumab, and Drug Combination for Patients with Unresectable Liver-Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Study on Long-Term Safety of Atogepant for Preventing Migraine in Patients with Chronic or Episodic Migraine

    Not recruiting

    3 1 1
    Investigated Drugs:
    Czechia Denmark France Germany Hungary Italy +3

  • Study on RZ358 for Treating Congenital Hyperinsulinism in Patients

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Denmark France Germany Greece Spain

  • Study of Tislelizumab, Dacarbazine, Vinblastine Sulfate, and Doxorubicin Hydrochloride for Adults with Early-Stage Unfavorable Hodgkin Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Germany

  • Study on the Effects of Inhaled ETD001 for People with Cystic Fibrosis

    Not recruiting

    2 1
    Investigated Drugs:
    France Germany Italy

  • Study on the Long-Term Safety of Darvadstrocel for Adults with Crohn’s Disease and Complex Perianal Fistulas

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Czechia France Germany Spain

  • Study on the Effectiveness and Safety of JNJ-77242113 for Treating Moderate to Severe Plaque Psoriasis in Adults

    Not recruiting

    3 1
    Investigated Drugs:
    France Germany Hungary Italy Poland Spain

  • Study on the Effectiveness and Safety of CAM2029 Compared to Octreotide and Lanreotide in Patients with Gastroenteropancreatic Neuroendocrine Tumors

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium France Germany Hungary Italy The Netherlands +2

  • Study on the Effects of Finerenone on Kidney Health in Patients with Type 2 Diabetes

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

powered by